DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
- 23 September 2009
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 20 (11) , 1269-1278
Abstract
We are evaluating the use of electroporation (EP) to deliver a novel DNA vaccine, p.DOM-PSMA 27 . This vaccine encodes a domain (DOM) of fragment C of tetanus toxin to induce CD4 + T cell help, fused to a tumor-derived epitope from prostate-specific membrane antigen (PSMA) for use in HLA-A2 + patients with recurrent prostate cancer. We report on safety and tolerability and on antibody response to DOM as a first indication of the effect of EP in patients. In this open label phase I/II, two-arm, dose escalation trial DNA was delivered either by intramuscular injection or by intramuscular injection followed by EP (DNA+EP), with five patients per dose level. Three vaccinations were given at 0, 4, and 8 weeks,with booster doses at 24 and 48 weeks; here we allowed crossover between study arms if supported by the safety and immunological data. In the 20 patients in the first two dose cohorts we observed that beyond brief and acceptable pain at the injection site, EP did not appear to add toxicity to the vaccination. We evaluated humoral responses to DOM. Low anti-DOM IgG antibody responses were observed after intramuscular injection of DNA without EP (at week 12: mean 1.7- vs. 24.5-fold increase over baseline with DNA+EP). These could be boosted by delivery of DNA+EP at later time points. Delivery of DNA+EP at all five vaccinations yielded the highest levels of anti-DOM antibody. Responses persisted to 18 months of follow-up. These data establish EP as a potent method for stimulating humoral responses induced by DNA vaccination in humans.Keywords
This publication has 35 references indexed in Scilit:
- Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating FactorJournal of Clinical Oncology, 2008
- TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccinesNature, 2008
- Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaquesVaccine, 2008
- In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T CellsThe Journal of Immunology, 2007
- Epidermal DNA vaccine for influenza is immunogenic in humansVaccine, 2006
- Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specificBlood, 2006
- Electroporation as a “Prime/Boost” Strategy for Naked DNA Vaccination against a Tumor AntigenThe Journal of Immunology, 2005
- Early events of electroporation‐mediated intramuscular DNA vaccination potentiate Th1‐directed immune responsesThe Journal of Gene Medicine, 2005
- Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in MiceThe Journal of Immunology, 2000
- Gene transfer into muscle by electroporation in vivoNature Biotechnology, 1998